GLP-1 LIVE w/ Dr. Stirrett - Ozempic, Tirzepatide, Retatrutide Microdosing Q&A
In this live session, Dr. Stirrett delves into the root causes of the so-called "Ozempic personality," explaining how over-titration and malnutrition suppress critical thyroid and testosterone hormones. He addresses community Q&A regarding microdosing strategies, breaking weight loss stalls, cycling peptides like NAD+ and CJC-1295/Ipamorelin, and optimizing liver markers when curbing alcohol consumption. Ultimately, he advocates for maintaining the lowest effective GLP-1 dosage paired with baseline blood work and strong nutritional foundations for long-term health.
1. Demystifying "Ozempic Personality" and the Root Cause of Fatigue
Dr. Stirrett kicks off the live session by addressing a trending topic circulating on social media: "Ozempic personality." This term describes patients walking around with a flat affect, low energy, depressed mood, and general apathy after starting GLP-1 therapy. While the term itself is somewhat dramatized, the underlying physiological phenomenon is very real.
"Ozempic personality, I think, is a little bit dramatized... but what tends to happen, and this is what I can see in blood work, is when somebody's been worked up to too high of a dosage and they're malnourished, what will happen is hormone suppression across the board."
When patients follow standard monthly titration schedules, doctors often push doses past the point of satiety, leading to severe malnutrition. This deficiency suppresses two vital hormone systems:
- Active Thyroid Hormone (Free T3): While overall TSH and inactive T4 may appear normal on routine labs, lacking essential micronutrients stops the conversion of inactive T4 into active Free T3. Low Free T3 slows metabolic rate, hampers weight loss, and dampens overall mood.
- Free Testosterone: In both men and women, severe caloric restriction depletes the essential building blocks needed for unbound free testosterone in circulation, causing drastic drops in recovery, physical energy, and enthusiasm.
To protect against this metabolic shutdown, establishing solid nutritional baselines is crucial. Consuming under 1,000–1,200 calories per day for women or under 1,800 calories per day for men serves as a major red flag for malnutrition 🚩.
[Standard Aggressive Titration] ➔ Severe Caloric Deficit ➔ Malnutrition
⬇
[Suppressed Free T3 & Free Testosterone]
⬇
[Fatigue, Low Mood & "Ozempic Personality"]
Additionally, protein intake becomes exponentially more important as we age. Biological absorption efficiency declines over time, meaning 10 grams of protein consumed at age 20 does not yield the same building blocks at age 50.
"10 g of protein at 20 years old is not the same at 50 years old... The older you are, the more you actually have to push and prioritize protein. They put the benchmark for all people over the age of 50 at 100 g per day."
Prioritizing higher protein intake (aiming toward 100g/day) while keeping GLP-1 doses low prevents muscle loss and protects overall mental well-being.
2. Long-Term Safety Evidence and Necessary Blood Work Baselines
When addressing concerns regarding the long-term safety of GLP-1 medications, Dr. Stirrett emphasizes that this class of peptides has a clinical history spanning over 10 years. They are safe when used with respect and proper medical oversight, rather than treated as a quick fix.
"These are real therapies... it's not to be taken lightly, and we want to be running regular blood work... to make sure that we're checking in on all the key markers that are going to be impacting your longevity, metabolic health, hormones, inflammation, and making sure that we're not doing more harm than good."
To ensure GLP-1 therapy remains supportive rather than detrimental, comprehensive blood panels should regularly monitor:
- Metabolic Markers: Fasting insulin (aiming for ~5 uIU/mL) and Hemoglobin A1C (aiming for 5.0–5.2%).
- Hormonal Balance: Free T3, Free Testosterone, and Cortisol.
- Inflammatory & Liver Markers: GGT, ALT, and AST enzymes.
- Nutritional Levels: Key vitamins and mineral storage (like ferritin).
3. Optimizing Injection Sites and Breaking Weight Loss Stalls
A common viewer question asks whether changing the injection site from the stomach to the thigh or glute helps break through a weight loss plateau.
"What the research says is that when you inject in the stomach, it has slightly higher effects of appetite suppression. However, with that comes a slightly higher side effect profile of the medication."
Dr. Stirrett recommends starting microdosing routines in the stomach to maximize receptor response at lower amounts. However, if a patient hits an unexpected plateau, switching injection sites to the thigh or outer glute can occasionally trigger a breakthrough momentum shift 🎯.
• Stomach: Highest appetite suppression | Slightly higher side-effect profile
• Thigh / Outer Glute: Milder response | Useful alternative for breaking plateaus
• Back of Arm: Generally less preferred in clinical practice
If local injection site irritation or redness occurs, practical solutions include:
- Cleaning the area thoroughly prior to administration.
- Injecting slightly deeper into the subcutaneous layer using insulin needles to prevent medication from getting trapped in shallow skin layers.
- Rotating locations systematically across injections.
- Requesting a fresh vial if contamination is suspected.
When weight loss stalls occur, blind dose increases shouldn't be the default reaction. Doctors should first evaluate digestive health (addressing constipation, bloating, or gas) and review full blood work to correct hidden metabolic hurdles.
4. Nuances of Testosterone Replacement Therapy (TRT) and Growth Hormone Peptides
Addressing Testosterone Replacement Therapy (TRT), Dr. Stirrett challenges the outdated medical dogma that "once you start testosterone, you must stay on it forever."
"My mentor had a very unique approach to testosterone therapy. He would basically use it as a short-term therapy... men and women start testosterone therapy choose to stay on it because they love the benefits... However, I also saw quite a few individuals that decided to come off of it, and in the process, they had changed a lot about their lifestyle... and their testosterone levels recovered much higher than they were when we initially tested."
For men coming off TRT, tapering down off exogenous testosterone directly can cause severe fatigue because blood concentrations fall below natural production levels. Instead, transitioning to therapies like enclomiphene or LH-stimulating peptides helps reactivate the testicles so natural production resumes smoothly.
Dr. Stirrett also compares popular growth hormone secretagogue peptides:
- Sermorelin: An older classic peptide often added by clinics. However, it can elevate cortisol, which indirectly raises blood sugar and counteracts fat loss goals over time.
- Tesamorelin: Specifically targeted for visceral abdominal fat, but clinical responses vary widely and costs remain high.
- Ipamorelin + CJC-1295: The standout combination for sleep quality, deep recovery, and body composition benefits with high patient satisfaction.
"Ipamorelin / CJC for growth hormone analogs—I've had a higher success rate there. And I literally have patients that tell me they can't live without it. It was the best thing they ever did for their performance, for their sleep."
5. Receptor Tolerance, Microdosing, and NAD+ Energy Boosting
A frequent concern among patients is whether GLP-1 medications inevitably stop working due to built-up receptor tolerance.
"Even at 11 mg, eventually your body will get used to the level of stimulation that the drug is providing... That's why I want to stay as low as possible with people because eventually, after 4 or 6 months, your body may become used to a dosage and you might need to just increase it slightly."
Microdosing leaves ample overhead room. If tolerance develops after several months on a low dosage, a tiny micro-adjustment (just a unit or two) re-engages receptor activity without forcing patients up to maximum tolerance limits.
[Standard Escalation] ➔ Rapid High Dosing ➔ Maxed Receptors ➔ No Room to Adjust
VS
[Microdosing Approach] ➔ Lowest Effective Dose ➔ Small Unit Tweaks ➔ Sustained Long-Term Progress
Furthermore, preserving a small amount of physiological hunger is actually healthy!
"We still want to be a little bit hungry on these meds. We don't want to shut it down all the way... because then it becomes very difficult to feed yourself."
To combat fatigue and boost cellular energetics during weight loss, NAD+ serves as a vital coenzyme for cellular ATP energy production. Natural NAD+ levels drop progressively with age. Dr. Stirrett highlights that subcutaneous NAD+ injections or transdermal iontophoresis patches deliver far superior cellular absorption compared to oral pills, which mostly break down during digestion ⚡.
"The best way to combat fatigue on a GLP-1 is not the NAD... it's dosage control and maintaining the lowest effective dosage of the GLP-1 where that's giving you some level of appetite suppression and not pushing past that."
6. Practical Tips: Alcohol Craving Suppression, Digestive Health, and Cost-Effective Options
GLP-1 therapies provide profound benefits for reducing alcohol consumption by curbing the impulse for evening drinks 🍷. For patients enjoying moderate alcohol, monitoring key liver enzyme baselines ensures safety:
Optimal Target Levels for Liver Enzymes:
• GGT (Gamma-Glutamyl Transferase): < 30 U/L (Indicates low liver inflammation)
• ALT (Alanine Aminotransferase) : < 30 U/L (Ideally < 20 U/L)
• AST (Aspartate Aminotransferase) : < 30 U/L (Ideally < 20 U/L)
If digestive side effects like intermittent diarrhea or nausea appear on GLP-1s, remember that delayed gastric emptying keeps foods in the stomach and gut longer. Inflammatory items (fried foods, heavy dairy, eating out) consumed 8–12 hours prior can trigger sudden flushing reactions. Auditing dietary triggers and supporting gut health usually resolves the issue.
Regarding cost barriers, switching from tirzepatide to compounded semaglutide offers an effective, budget-friendly alternative. When transitioning between peptides, start near the lower end of the dosing schedule for safety, but expect to titrate up slightly faster to match established receptor tolerance.
When patients need to pause GLP-1 therapy for upcoming surgeries, the primary reason is anesthesia risk due to delayed stomach emptying. GLP-1s are typically paused 1 to 2 weeks before surgery and can usually be safely resumed during early post-operative recovery once approved by the surgical team.
Wrapping Up
Managing weight loss and metabolic health on GLP-1 therapies requires a balanced, patient-centered approach. Pushing doses too aggressively leads to malnutrition, fatigue, and hormone suppression. By utilizing microdosing, tracking baseline blood work, prioritizing protein intake, and maintaining healthy gut foundations, patients achieve sustainable, long-term success while feeling energized throughout their wellness journey! 🌿
Need a summary like this?
Get instant summaries with Harvest